- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06742372
Effects of Combined Exercise Training Modality
December 16, 2024 updated by: Zeliha ÇELİK, Gazi University
Effects of Combined Exercise Training Modality on Diaphragm Function and Performance
This study aims to investigate the effects of combined Inspiratory Muscle Training and aerobic exercise on diaphragm and pulmonary functions, respiratory muscle function, performance, and body composition
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
24
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Amasya, Turkey
- Amasya University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:aged between 18 and 40 years who have physical activity levels above 600 MET-min/week -
Exclusion Criteria:Individuals who were diagnosed with any cardiopulmonary or other chronic diseases, have any infections or limitations preventing them from doing an activity during assessment or intervention, do exercise regularly, and have smoked over 10 pack-years
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: combined inspiratory and aerobic exercise training
|
combined inspiratory and aerobic exercise training will be performed in healthy individuals
|
|
Experimental: aerobic exercise training
|
aerobic exercise training will be performed in healthy individuals
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Respiratory muscle strength
Time Frame: First day
|
Maximal inspiratory and expiratory muscle strength will be evaluated using mouth pressure device .
|
First day
|
|
diaphragm thickness
Time Frame: Second day
|
Second day
|
|
|
diaphragm stiffness
Time Frame: Second day
|
Second day
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Inspiratory muscle endurance
Time Frame: First day
|
First day
|
|
FEV1
Time Frame: First day
|
First day
|
|
FVC
Time Frame: First day
|
First day
|
|
FEV1/FVC
Time Frame: First day
|
First day
|
|
PEF
Time Frame: First day
|
First day
|
|
FEF2575
Time Frame: First day
|
First day
|
|
Running Based Anaerobic Sprint Test (RAST test)
Time Frame: Second day
|
Second day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 12, 2023
Primary Completion (Estimated)
December 31, 2024
Study Completion (Estimated)
March 31, 2025
Study Registration Dates
First Submitted
December 16, 2024
First Submitted That Met QC Criteria
December 16, 2024
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
December 16, 2024
Last Verified
December 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- 310783
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Individuals (Controls)
-
Haute Ecole Bruxelles-BrabantCompletedHealthy | Healthy Individuals (Controls)Belgium
-
China National Center for Cardiovascular DiseasesEnrolling by invitationHealthy Individuals (Controls)China
-
Eskisehir Osmangazi UniversityEnrolling by invitationHealthy Individuals (Controls) | PRIMARY HYPERTENSION PATIENTTurkey (Türkiye)
-
Bezmialem Vakif UniversityNot yet recruitingDiabetic Polyneuropathy | Healthy Individuals (Controls)
-
Virginia Commonwealth UniversityNational Institute on Drug Abuse (NIDA)Not yet recruiting
-
Laureate Institute for Brain Research, Inc.Recruiting
-
Hospices Civils de LyonCompleted
-
University of ZurichCompleted
-
Massachusetts General HospitalCompletedHealthy ControlsUnited States
-
University of North Carolina, Chapel HillNational Institute of Environmental Health Sciences (NIEHS)Terminated
Clinical Trials on combined inspiratory and aerobic exercise training
-
VA Office of Research and DevelopmentCompletedHeart FailureUnited States
-
Lebanese UniversityCompletedHeart Failure | Quality of Life | Cardiac Rehabilitation | Aerobic Exercise | Exercise Intolerance | Respiratory Muscle Training | Strength Training
-
Cairo UniversityCompleted
-
Ankara Yildirim Beyazıt UniversityCompletedPhysical TherapyTurkey
-
Gazi UniversityRecruitingPrimary ImmunodeficiencyTurkey
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São PauloCompletedCongenital Heart Disease | Univentricular Heart | Single VentricleBrazil
-
Riphah International UniversityNot yet recruiting
-
Onassis Cardiac Surgery CentreInstitute of Cardiology, Warsaw, Poland; Asklepieion Voulas General HospitalCompletedHeart FailureGreece, Poland
-
Biruni UniversityIstanbul Galata UniversityCompleted
-
Mehmet İsmail TOSUNCompletedChronic Obstructive Pulmonary Disease (COPD)Turkey (Türkiye)